---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-075294"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2022-06-28T23:59:59+00:00"
generated_at: "2026-06-24T22:32:37.426756+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 500,000-share increase and extension of 2015 Stock Incentive Plan to 2032

## Summary
- Plan share reserve increased by 500,000 to 11.5M shares; expiration extended to April 25, 2032.
- All 9 director nominees elected with majority vote; advisory say-on-pay passed with 38.9M for, 0.7M against.
- Plan amendment received 34.8M votes for (85.8% of votes cast); Ernst & Young ratified as auditor for 2022.
- Amendment effective June 27, 2022; prior plan was approved by shareholders in June 2021.

## SEC filing metadata
- accession: 0001104659-22-075294
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2022-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/0001104659-22-075294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/tm2219474d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-075294
- JSON: https://secwatch.observer/filing/0001104659-22-075294.json
- Plain text: https://secwatch.observer/filing/0001104659-22-075294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.